Winton Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,887
| Closed | -$1.05M | – | 1127 |
|
|
2022
Q2 | $1.05M | Buy |
13,887
+2,477
| +22% | +$186K | 0.06% | 473 |
|
|
2022
Q1 | $306K | Buy |
11,410
+1,849
| +19% | +$49.6K | 0.02% | 811 |
|
|
2021
Q4 | $456K | Sell |
9,561
-933
| -9% | -$44.5K | 0.03% | 703 |
|
|
2021
Q3 | $697K | Buy |
10,494
+1,737
| +20% | +$115K | 0.04% | 691 |
|
|
2021
Q2 | $683K | Sell |
8,757
-677
| -7% | -$52.8K | 0.04% | 743 |
|
|
2021
Q1 | $892K | Sell |
9,434
-1,334
| -12% | -$126K | 0.05% | 533 |
|
|
2020
Q4 | $1.31M | Sell |
10,768
-27,586
| -72% | -$3.36M | 0.09% | 272 |
|
|
2020
Q3 | $3.35M | Buy |
+38,354
| New | +$3.35M | 0.11% | 279 |
|